Trinity Biotech (TRIB)
0.64
-0.03 (-4.12%)
At close: Mar 28, 2025, 3:39 PM
0.64
0.00%
After-hours: Mar 28, 2025, 06:32 PM EDT
Trinity Biotech Revenue Breakdown
| Quarter | Jun 30, 2022 |
|---|---|
| Clinical Laboratory Revenue | 29.53M |
| Clinical Laboratory Revenue Growth | n/a |
| Laboratory Services Revenue | 3.7M |
| Laboratory Services Revenue Growth | n/a |
Revenue by Geography
| Quarter | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|
| America Revenue | 32.28M | 40.18M |
| America Revenue Growth | -19.65% | n/a |
| Ireland Revenue | 12.72M | n/a |
| Ireland Revenue Growth | n/a | n/a |
Operating Expense Breakdown
| Quarter | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 6.52M | 6.42M | 6.98M | 6.48M | 7.68M | 7.91M | 8.63M | 10.19M | 5.79M | 7.06M | 6.13M | 5.33M | 6.13M | 6.59M | 6.4M | 7.15M | 6.43M | 5.22M | 6.22M | 6.52M | 7.53M | 6.81M | 6.73M | 6.96M | 7.48M | 7.69M | 7.37M | 7.86M | 8.03M | 7.69M | 7.28M | 7.58M | 7.72M | 8.27M | 7.23M | 6.19M | 7.79M | 7.19M | 6.84M |
| Selling, General, and Administrative Revenue Growth | +1.46% | -7.93% | +7.67% | -15.65% | -2.83% | -8.42% | -15.27% | +75.93% | -17.94% | +15.07% | +15.00% | -13.03% | -6.96% | +3.00% | -10.48% | +11.18% | +23.18% | -16.08% | -4.65% | -13.34% | +10.56% | +1.16% | -3.28% | -6.99% | -2.69% | +4.24% | -6.18% | -2.07% | +4.36% | +5.67% | -4.03% | -1.80% | -6.56% | +14.35% | +16.71% | -20.54% | +8.46% | +4.98% | n/a |
| Research and Development Revenue | 1.01M | 991K | 1.09M | 1.12M | 1.17M | 1.23M | 860K | 1.17M | 1.02M | 984K | 965K | 941K | 1.06M | 1.06M | 1.44M | 1.28M | 1.26M | 1.15M | 1.38M | 1.33M | 1.23M | 1.45M | 1.31M | 1.39M | 1.29M | 1.42M | 1.27M | 1.54M | 1.47M | 1.32M | 1.33M | 1.33M | 1.3M | 1.27M | 1.15M | 1.51M | 1.29M | 1.27M | 998K |
| Research and Development Revenue Growth | +1.92% | -9.00% | -2.51% | -4.45% | -5.19% | +43.37% | -26.24% | +13.98% | +3.96% | +1.97% | +2.55% | -11.48% | +0.66% | -26.51% | +11.92% | +1.50% | +9.71% | -16.33% | +3.45% | +8.03% | -14.91% | +10.53% | -5.41% | +7.28% | -8.95% | +11.56% | -17.35% | +4.77% | +11.12% | -0.45% | -0.15% | +2.62% | +2.29% | +10.46% | -23.94% | +16.63% | +1.89% | +27.15% | n/a |